Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 April 1999

Influence of immunosupressive drugs on liver regeneration after partial hepatectomy in rats - experimental studies

Wojciech G. Polak

Med Sci Monit 1999; 5(3): BR405-409 :: ID: 504729

Abstract

The aim of this study was to asses the influence of selected immunosuppressants on liver regeneration in rats. Material and methods: In sixty male Buffalo strain rats partial hepatectomy (60-65%) was carried out according to Higgins and Anderson under ether anaesthesia. The observation of the rats lasted 6 weeks and 42 days after operation all animals were sacrificed. Rats were randomly assigned to one of six group (10 rats per group) and treated as follows: group 1 - without immunosuppressant (control group), group 2 - cyclosporin A, group 3 - azathioprine, group 4 - tacrolimus, group 5 - prednisolone, group 6 - triple drug therapy (TDT) - azathioprine with cyclosporin A and prednisolone. All rats in each group had following laboratory investigations in blood serum: aspartate aminotransferase (AspAT) activity, alanine aminotransferase (AlAT) activity and alkaline phosphatase (AP) activity. The above parameters were assessed one day before operation and then in 21st and 42nd day after hepatectomy. After 42 days observation all rats were killed and the remnant liver were removed for investigation of hepatic restoration and histologic features. Histologic examination of all sections was performed in light microscope. Furthermore resected liver tissue was weighed the day of operation and also the remnant liver was weighed after sacrification of the animal to calculate the regenerative rate. When applicable the comparison for statistical significance was performed according to the Student's test, Scheffe's test and analysis of variance. A p value of<0.05 was considered to represent a significant difference. Result and conclusions. Regenerative rate of liver tissue was significantly higher in rats treated with cyclosporin A and tacrolimus and significantly lower in rats treated with prednisolone and TDT. There were no significant difference between control group and rats treated with azathioprine. All immunosupressants used in this study influenced on liver function parameters as AspAT, AlAT and AP activity, but the changes were temporary. Histologic examination revealed in 3 rats treated with cyclosporin A restoration nodules with hepatocytes regeneration. In two rats treated with azathioprine there was observed adenocarcinoma coming from bile ducts. One rat treated with tacrolimus presented acute, diffuse necrosis of central parts of hepatic lobules. This study has shown that among immunosupressant used in this experiment only cyclosporin A and tacrolimus stimulated liver regeneration after partial hepatectomy. On the other hand prednisolone and triple drug therapy inhibited liver regeneration, whereas azathioprine had no influence on liver restoration. In some rats treated with cyclosporin A restoration nodules with hepatocytes regeneration occured. In rats receiving azathioprine there were observed two cases of cholangiocarcinoma.

Keywords: Rat, histological examination, regenerative rate, regenerative rate, Tacrolimus, Steroids, Steroids, azathioprine

0 Comments

Editorial

01 February 2023 : Editorial  

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939580

Med Sci Monit 2023; 29:e939580

SARS-CoV-2/COVID-19

19 January 2023 : Clinical Research  

Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...

Med Sci Monit In Press; DOI: 10.12659/MSM.938892  

27 December 2022 : Clinical Research  

Effect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...

Med Sci Monit 2022; 28:e938926

10 December 2022 : Clinical Research  

Retrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...

Med Sci Monit 2022; 28:e938647

In Press

03 Feb 2023 : Clinical Research  

Treatment of Gingival Recession Defects with Pouch and Tunnel Technique Using Connective Tissue Graft and L...

Med Sci Monit In Press; DOI: 10.12659/MSM.938865  

02 Feb 2023 : Clinical Research  

Online Questionnaire-Based Study to Evaluate the Attitudes and Use of Rubber Dental Dams by Saudi Dental Pr...

Med Sci Monit In Press; DOI: 10.12659/MSM.938672  

02 Feb 2023 : Database Analysis  

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based...

Med Sci Monit In Press; DOI: 10.12659/MSM.938785  

01 Feb 2023 : Clinical Research  

Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibo...

Med Sci Monit In Press; DOI: 10.12659/MSM.939084  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750